GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (FRA:D4S) » Definitions » Cyclically Adjusted FCF per Share

Daiichinkyo Co (FRA:D4S) Cyclically Adjusted FCF per Share : €0.40 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Daiichinkyo Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.056. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.40 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Daiichinkyo Co's average Cyclically Adjusted FCF Growth Rate was 70.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 19.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Daiichinkyo Co was 19.00% per year. The lowest was 1.00% per year. And the median was 2.00% per year.

As of today (2024-05-15), Daiichinkyo Co's current stock price is €32.66. Daiichinkyo Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.40. Daiichinkyo Co's Cyclically Adjusted Price-to-FCF of today is 81.65.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Daiichinkyo Co was 135.66. The lowest was 21.98. And the median was 67.86.


Daiichinkyo Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Daiichinkyo Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Cyclically Adjusted FCF per Share Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.29 0.27 0.25 0.40

Daiichinkyo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.21 0.21 0.42 0.40

Competitive Comparison of Daiichinkyo Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Cyclically Adjusted Price-to-FCF falls into.



Daiichinkyo Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Daiichinkyo Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.056/107.2000*107.2000
=-0.056

Current CPI (Mar. 2024) = 107.2000.

Daiichinkyo Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.016 98.000 0.018
201409 0.046 98.500 0.050
201412 0.066 97.900 0.072
201503 0.033 97.900 0.036
201506 -0.028 98.400 -0.031
201509 0.092 98.500 0.100
201512 0.062 98.100 0.068
201603 0.247 97.900 0.270
201606 0.107 98.100 0.117
201609 0.097 98.000 0.106
201612 -0.022 98.400 -0.024
201703 0.167 98.100 0.182
201706 -0.040 98.500 -0.044
201709 0.049 98.800 0.053
201712 0.057 99.400 0.061
201803 0.204 99.200 0.220
201806 -0.097 99.200 -0.105
201809 0.024 99.900 0.026
201812 0.017 99.700 0.018
201903 0.161 99.700 0.173
201906 0.269 99.800 0.289
201909 0.057 100.100 0.061
201912 0.089 100.500 0.095
202003 0.197 100.300 0.211
202006 0.072 99.900 0.077
202009 0.200 99.900 0.215
202012 0.052 99.300 0.056
202103 0.201 99.900 0.216
202106 -0.207 99.500 -0.223
202109 0.171 100.100 0.183
202112 0.208 100.100 0.223
202203 0.085 101.100 0.090
202206 -0.150 101.800 -0.158
202209 0.198 103.100 0.206
202212 0.067 104.100 0.069
202303 0.057 104.400 0.059
202306 -0.248 105.200 -0.253
202309 -0.135 106.200 -0.136
202312 2.017 106.800 2.025
202403 -0.056 107.200 -0.056

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Daiichinkyo Co  (FRA:D4S) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Daiichinkyo Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=32.66/0.4
=81.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Daiichinkyo Co was 135.66. The lowest was 21.98. And the median was 67.86.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Daiichinkyo Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Daiichinkyo Co (FRA:D4S) Business Description

Traded in Other Exchanges
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (FRA:D4S) Headlines

No Headlines